Skip to main content

Advertisement

SpringerLink
Log in

Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease

  • Original Article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

McArdle disease (MD) is a metabolic myopathy caused by deficiency of the myophosphorylase enzyme. The aim of our study was to analyse a series of MD patients in Brazil and the correlation between clinical findings, laboratory data, electromyography, muscle biopsy and genetic features. The PYGM gene was analysed by PCR/RLFP and Sanger sequencing. The sample included 12 patients, aged 18–57 years, from unrelated families. Exercise intolerance was present in all cases. Serum creatine kinase levels at rest were increased in all patients. Forearm ischaemic exercise testing in five patients revealed no increase in venous lactate. Needle electromyography presented ‘myopathic pattern’ in six patients. Muscle biopsy showed vacuolar myopathy in 10 patients and deficiency of myophosphorylase enzyme in all patients. The genetic analysis showed p.R50X as the most common mutation (allelic frequency: 56.25%), other known mutations (p.Y574X, p.G205S, p.W798R, IVS14 + 1G > A and IVS19-1G > A) and a new mutation (p.Asn168Lysfs*15) were also identified. Several features of the disorder were similar to the vast majority of patients worldwide. The genetic findings of this study revealed a range of mutations that are quite similar to the European cohort. The discovery of one novel mutation increases the genotypic heterogeneity of PYGM gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fernandez R, Navarro C, Andreu AL, Bruno C, Shanske S, Gamez J et al (2000) A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease. Arch Neurol 57:217–219

    Article  CAS  Google Scholar 

  2. Santalla A, Nogales-Gadea G, Encinar AB, Vieitez I, Gonzalez-Quintana A, Serrano-Lorenzo P et al (2017) Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update. BMC Genom 18(Suppl 8):819

    Article  Google Scholar 

  3. De Castro M, Johnston J, Biesecker L (2015) Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data. Genet Med 17:1002–1006

    Article  Google Scholar 

  4. Vieitez I, Teijeira S, Fernandez JM, San Millan B, Miranda S, Ortolano S et al (2011) Molecular and clinical study of McArdle’s disease in a cohort of 123 European patients. Identification of 20 novel mutations. Neuromuscul Disord 21:817–823

    Article  Google Scholar 

  5. Martinuzzi A, Tsujino S, Vergani L, Schievano G, Cadaldini M, Bartoloni L et al (1996) Molecular characterization of myophosphorylase deficiency in a group of patients from northern Italy. J Neurol Sci 137:14–19

    Article  CAS  Google Scholar 

  6. Deschauer M, Morgenroth A, Joshi PR, Glaser D, Chinnery PF, Aasly J et al (2007) Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations. J Neurol 254:797–802

    Article  CAS  Google Scholar 

  7. Scalco RS, Morrow JM, Booth S, Chatfield S, Godfrey R, Quinlivan R (2017) Misdiagnosis is an important factor for diagnostic delay in McArdle disease. Neuromusc Dis 27:852–855

    Article  Google Scholar 

  8. Kubisch C, Wicklein EM, Jentsch TJ (1998) Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation. Hum Mutat 12:27–32

    Article  CAS  Google Scholar 

  9. Quinlivan R, Andreu AL, Marti R (2017) 211th ENMC international workshop: development of diagnostic criteria and management strategies for McArdle disease and related rare glycogenolytic disorders to improve standards of care 17–19th April 2015 Naarden, Netherlands. Neuromuscul Disord 27:1143–1151

    Article  Google Scholar 

  10. Martin MA, Rubio JC, Buchbinder J, Fernandez-Hojas R, del Hoyo P, Teijeira S et al (2001) Molecular heterogeneity of myophosphorylase deficiency (McArdle’s disease): a genotype-phenotype correlation study. Ann Neurol 50:574–581

    Article  CAS  Google Scholar 

  11. Inal-Gültekin G, Toptas-Hekimoglu B, Görmez Z, Gelisin O, Durmus H, Erquner B et al (2017) Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease. Neuromusc Dis 27:997–1008

    Article  Google Scholar 

  12. Lorenzoni PJ, Silvado CE, Scola RH, Luvizotto M, Werneck LC (2007) McArdle disease with rhabdomyolysis induced by rosuvastatin: case report. Arq Neuropsiquiatr 65:834–837

    Article  Google Scholar 

  13. Lorenzoni PJ, Lange MC, Kay CS, Scola RH, Werneck LC (2005) Motor nerve conduction study in McArdle disease: case report. Arq Neuropsiquiatr 63:874–877

    Article  Google Scholar 

  14. Gurgel-Giannetti J, Nogales-Gadea G, van der Linden H Jr, Bellard TM, Brasileiro Filho G, Giannetti AV et al (2013) Clinical and molecular characterization of McArdle’s disease in Brazilian patients. Neuromol Med 15:470–475

    Article  CAS  Google Scholar 

  15. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, Visser M (2014) Rhabdomyolysis: review of the literature. Neuromusc Dis 24:651–659

    Article  CAS  Google Scholar 

  16. Martinuzzi A, Sartori E, Fanin M, Nascimbeni A, Valente L, Angelini C et al (2003) Phenotype modulators in myophosphorylase deficiency. Ann Neurol 53:497–502

    Article  CAS  Google Scholar 

  17. Werneck LC (1981) The value of muscle biopsy in neurology: a study of 290 biopsies. Rev Bras Clin Ter 10(Suppl):2–24

    Google Scholar 

  18. Andreu AL, Nogales-Gadea G, Cassandrini D, Arenas J, Bruno C (2007) McArdle disease: molecular genetic update. Acta Myol 26:53–57

    CAS  PubMed  PubMed Central  Google Scholar 

  19. García-Consuegra I, Asensio-Peña S, Ballester-Lopez A, Francisco-Velilla R, Pinos T, Pintos-Morell G et al (2018) Missense mutations have unexpected consequences: the McArdle disease paradigm. Hum Mutat 2018 39:1338–1343

    Article  Google Scholar 

  20. Tsujino S, Shanske S, DiMauro S (1993) Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle’s disease). N Engl J Med 329:241–245

    Article  CAS  Google Scholar 

  21. Hogrel JY, van den Bogaart F, Ledoux I, Ollivier G, Petit F, Koujah N et al (2015) Diagnostic power of the non-ischaemic forearm exercise test in detecting glycogenosis type V. Eur J Neurol 22:933–940

    Article  Google Scholar 

  22. Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J (2002) A nonischemic forearm exercise test for McArdle disease. Ann Neurol 52:153–159

    Article  Google Scholar 

  23. Lindner A, Reichert N, Eichhorn M, Zierz S (2001) Acute compartment syndrome after forearm ischemic work test in a patient with McArdle’s disease. Neurology 56:1779–1780

    Article  CAS  Google Scholar 

  24. Henning F, Cunninghame CA, Martin MA, Rubio JC, Arenas J, Lucia A et al (2017) Muscle fiber type proportion and size is not altered in McArdle disease. Muscle Nerve 55:916–917

    Article  CAS  Google Scholar 

  25. Nogales-Gadea G, Brull A, Santalla A, Andreu AL, Arenas J, Martin MA et al (2015) McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat 36:669–678

    Article  CAS  Google Scholar 

  26. Garcia-Consuegra I, Blázquez A, Rubio JC, Arenas J, Ballester-Lopez A, González-Quintana A et al (2016) Taking advantage of an old concept, “illegitimate transcription”, for a proposed novel method of genetic diagnosis of McArdle disease. Genet Med 18:1128–1135

    Article  CAS  Google Scholar 

  27. Garcia-Consuegra I, Rubio JC, Nogales-Gadea G, Bautista J, Jimenez S, Cabello A et al (2009) Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA. J Med Genet 46:198–202

    Article  CAS  Google Scholar 

  28. Bruno C, Cassandrini D, Martinuzzi A, Toscano A, Moggio M, Morandi L et al (2006) McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Hum Mutat 27:718

    Article  Google Scholar 

  29. Gámez J, Rubio JC, Martín MA, Fernandez-Cadenas I, Garcia-Arumi E, Anreu AL et al (2003) Two novel mutations in the muscle glycogen phosphorylase gene in McArdle’s disease. Muscle Nerve 28:380–382

    Article  Google Scholar 

  30. Rubio JC, Martín MA, Campos Y, Auciello R, Cabello A, Arenas J (2000) A missense mutation W797R in the myophosphorylase gene in a Spanish patient with McArdle’s disease. Muscle Nerve 23:129–131

    Article  CAS  Google Scholar 

  31. Tsujino S, Shanske S, Nonaka I, Eto Y, Mendell JR, Fenichel GM et al (1994) Three new mutations in patients with myophosphorylase deficiency (McArdle disease). Am J Hum Genet 54:44–52

    Article  CAS  Google Scholar 

  32. Moro A, Munhoz RP, Arruda WO, Raskin S, Moscovich M, Teive HA (2014) Spinocerebellar ataxia type 3: subphenotypes in a cohort of Brazilian patients. Arq Neuropsiquiatr 72:659–662

    Article  Google Scholar 

  33. Mihaylova V, Scola RH, Gervini B, Lorenzoni PJ, Kay CK, Werneck LC et al (2010) Molecular characterisation of congenital myasthenic syndromes in Southern Brazil. J Neurol Neurosurg Psychiatry 81:973–977

    Article  CAS  Google Scholar 

  34. Cruz MW (2012) Regional differences and similarities of familial amyloidotic polyneuropathy (FAP) presentation in Brazil. Amyloid Suppl 1:65–67

    Article  Google Scholar 

Download references

Funding

This study was supported by UFPR, Fundação Araucária, CAPES and CNPq.

Author information

Authors and Affiliations

  1. Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, 80060-900, Brazil

    Paulo José Lorenzoni, Lineu Cesar Werneck, Cláudia Suemi Kamoi Kay, Raquel Cristina Arndt, Carlos E. S. Silvado & Rosana Herminia Scola

Authors
  1. Paulo José Lorenzoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lineu Cesar Werneck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cláudia Suemi Kamoi Kay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raquel Cristina Arndt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carlos E. S. Silvado
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rosana Herminia Scola
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rosana Herminia Scola.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study was approved by the Local Ethics Committee for Human Research.

Informed consent

All studies were conducted in accordance with ethical principles after obtaining patient consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lorenzoni, P.J., Werneck, L.C., Kay, C.S.K. et al. Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease. Acta Neurol Belg 120, 303–311 (2020). https://doi.org/10.1007/s13760-018-1038-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-018-1038-1

Keywords

Search

Navigation